相关实验视频

Updated: May 8, 2026

An In Vitro Model to Study the Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy on Staphylococcus aureus Biofilm

An In Vitro Model to Study the Effect of 5-Aminolevulinic Acid-mediated Photodynamic Therapy on Staphylococcus aureus Biofilm

Published on: April 16, 2018

基于pH响应的库尔库含有黄素的利性伊米达酸框架-8药物输送系统对黄金菌感染的保护作用

Meijuan Meng¹, Ran Huo¹, Zhixin Li²

¹College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, Jiangsu Province, PR China.

Microbial pathogenesis

|January 26, 2025

概括

一种新的纳米药物输送系统,ZIF-8@CCM,有效地治疗牛的金黄色葡萄球菌 (S. aureus) 乳腺炎. 该系统提供黄素,减少炎症和细菌负载,无需担心抗菌素耐药性问题.

科学领域:

兽医医学兽医医学兽医医学
材料科学材料科学材料科学
纳米技术纳米技术

背景情况:

乳腺炎是一种重要的奶牛养殖疾病,通常是由金黄色葡萄球菌 (S. aureus) 引起的,导致乳腺损伤.
乳腺炎的抗生素治疗是常见的,但有助于抗菌素耐药性,需要替代治疗策略.
焦油性伊米达酸框架 (ZIF-8) 由于其生物相容性和可调节性质,是药物输送系统的一个有前途的材料.

研究的目的:

开发和评估一种新的纳米药物输送系统,ZIF-8@CCM,用于针对性治疗S. aureus诱导的乳腺炎.
评估ZIF-8@CCM在体外和体内抗菌和抗炎功效.
研究ZIF-8@CCM系统的作用机制和生物相容性.

主要方法:

合成ZIF-8纳米颗粒加载的黄素 (ZIF-8@CCM).
在体外评估使用牛乳腺上皮细胞 (BMEC) 和金黄色菌种.
在小鼠体内研究以评估治疗疗效,生物相容性和炎症途径.
对药物释放动力学,生物膜抑制和TLR2-NF-κB通路调节的分析.

主要成果:

ZIF-8@CCM表现出高药物负载,稳定性和pH响应的黄素释放.
该系统在体外和体内表现出强大的抗菌活性,对黄金色杆菌,包括生物膜预防.
通过抑制TLR2-NF-κB通路,ZIF-8@CCM有效降低了S. aureus诱导的炎症,显示出良好的生物利用性和生物相容性.

结论:

ZIF-8@CCM是一种有前途的向抗菌和抗炎药物,用于治疗黄金杆菌乳腺炎.
这种纳米药物输送系统为传统抗生素提供了替代方案,减轻了抗菌素耐药性的风险.
这项研究突出了基于ZIF-8的纳米材料在兽医中治疗传染病的潜力.

关键词:

抗菌的抗菌的抗菌的库尔库明是一种黄素.炎症炎症是一种炎症.在 ZIF-8@CCM 发送.黄金葡萄球菌黄金葡萄球菌.

更多相关视频

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Published on: September 8, 2021

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

相关概念视频

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Staphylococcal Skin Infections

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...